Estimating The Fair Value Of Cardlytics, Inc. (NASDAQ:CDLX)
Our analysis shows Cardlytics' fair value estimate is 19% lower than analysts' price target. Using the Discounted Cash Flow model, we evaluate the company's intrinsic value by projecting future cash flows. This 2-stage growth model considers different growth rates over time.